BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 12639928)

  • 1. Glucagon-like peptide-1 inhibits apoptosis of insulin-secreting cells via a cyclic 5'-adenosine monophosphate-dependent protein kinase A- and a phosphatidylinositol 3-kinase-dependent pathway.
    Hui H; Nourparvar A; Zhao X; Perfetti R
    Endocrinology; 2003 Apr; 144(4):1444-55. PubMed ID: 12639928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The long-acting glucagon-like peptide-1 analogue, liraglutide, inhibits beta-cell apoptosis in vitro.
    Bregenholt S; Møldrup A; Blume N; Karlsen AE; Nissen Friedrichsen B; Tornhave D; Knudsen LB; Petersen JS
    Biochem Biophys Res Commun; 2005 May; 330(2):577-84. PubMed ID: 15796922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ligand-induced regulation of glucagon-like peptide-I receptor function and expression in insulin-secreting beta cells.
    Fehmann HC; Jiang J; Pitt D; Schweinfurth J; Göke B
    Pancreas; 1996 Oct; 13(3):273-82. PubMed ID: 8884849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucagon-like peptide 1 elevates cytosolic calcium in pancreatic beta-cells independently of protein kinase A.
    Bode HP; Moormann B; Dabew R; Göke B
    Endocrinology; 1999 Sep; 140(9):3919-27. PubMed ID: 10465260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucagon-like peptide 1 inhibits cell apoptosis and improves glucose responsiveness of freshly isolated human islets.
    Farilla L; Bulotta A; Hirshberg B; Li Calzi S; Khoury N; Noushmehr H; Bertolotto C; Di Mario U; Harlan DM; Perfetti R
    Endocrinology; 2003 Dec; 144(12):5149-58. PubMed ID: 12960095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucagon-like peptide 1 prevents reactive oxygen species-induced endothelial cell senescence through the activation of protein kinase A.
    Oeseburg H; de Boer RA; Buikema H; van der Harst P; van Gilst WH; Silljé HH
    Arterioscler Thromb Vasc Biol; 2010 Jul; 30(7):1407-14. PubMed ID: 20448207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancreatic beta-cells expressing GLP-1 are resistant to the toxic effects of immunosuppressive drugs.
    D'Amico E; Hui H; Khoury N; Di Mario U; Perfetti R
    J Mol Endocrinol; 2005 Apr; 34(2):377-90. PubMed ID: 15821104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The glucagon-like peptide-2 receptor mediates direct inhibition of cellular apoptosis via a cAMP-dependent protein kinase-independent pathway.
    Yusta B; Boushey RP; Drucker DJ
    J Biol Chem; 2000 Nov; 275(45):35345-52. PubMed ID: 10940305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucagon-like peptide 1 stimulates insulin gene promoter activity by protein kinase A-independent activation of the rat insulin I gene cAMP response element.
    Skoglund G; Hussain MA; Holz GG
    Diabetes; 2000 Jul; 49(7):1156-64. PubMed ID: 10909973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dipeptidyl Peptidase 4 Inhibition Alleviates Shortage of Circulating Glucagon-Like Peptide-1 in Heart Failure and Mitigates Myocardial Remodeling and Apoptosis via the Exchange Protein Directly Activated by Cyclic AMP 1/Ras-Related Protein 1 Axis.
    Aoyama M; Kawase H; Bando YK; Monji A; Murohara T
    Circ Heart Fail; 2016 Jan; 9(1):e002081. PubMed ID: 26721911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein kinase Czeta activation mediates glucagon-like peptide-1-induced pancreatic beta-cell proliferation.
    Buteau J; Foisy S; Rhodes CJ; Carpenter L; Biden TJ; Prentki M
    Diabetes; 2001 Oct; 50(10):2237-43. PubMed ID: 11574404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucagon-like peptide-1 stimulates type 3 iodothyronine deiodinase expression in a mouse insulinoma cell line.
    Akiyama S; Ogiwara T; Aoki T; Tsunekawa K; Araki O; Murakami M
    Life Sci; 2014 Oct; 115(1-2):22-8. PubMed ID: 25241124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucagon-like peptide-1 promotes DNA synthesis, activates phosphatidylinositol 3-kinase and increases transcription factor pancreatic and duodenal homeobox gene 1 (PDX-1) DNA binding activity in beta (INS-1)-cells.
    Buteau J; Roduit R; Susini S; Prentki M
    Diabetologia; 1999 Jul; 42(7):856-64. PubMed ID: 10440129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulinotropic hormone glucagon-like peptide 1 (GLP-1) activation of insulin gene promoter inhibited by p38 mitogen-activated protein kinase.
    Kemp DM; Habener JF
    Endocrinology; 2001 Mar; 142(3):1179-87. PubMed ID: 11181533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatostatin inhibits glucagon-like peptide-1-induced insulin secretion and proliferation of RINm5F insulinoma cells.
    Stark A; Mentlein R
    Regul Pept; 2002 Oct; 108(2-3):97-102. PubMed ID: 12220732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obestatin promotes survival of pancreatic beta-cells and human islets and induces expression of genes involved in the regulation of beta-cell mass and function.
    Granata R; Settanni F; Gallo D; Trovato L; Biancone L; Cantaluppi V; Nano R; Annunziata M; Campiglia P; Arnoletti E; Ghè C; Volante M; Papotti M; Muccioli G; Ghigo E
    Diabetes; 2008 Apr; 57(4):967-79. PubMed ID: 18162507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Desensitization and phosphorylation of the glucagon-like peptide-1 (GLP-1) receptor by GLP-1 and 4-phorbol 12-myristate 13-acetate.
    Widmann C; Dolci W; Thorens B
    Mol Endocrinol; 1996 Jan; 10(1):62-75. PubMed ID: 8838146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antagonism of rat beta-cell voltage-dependent K+ currents by exendin 4 requires dual activation of the cAMP/protein kinase A and phosphatidylinositol 3-kinase signaling pathways.
    MacDonald PE; Wang X; Xia F; El-kholy W; Targonsky ED; Tsushima RG; Wheeler MB
    J Biol Chem; 2003 Dec; 278(52):52446-53. PubMed ID: 14565957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucagon-like peptide-1 promotes islet cell growth and inhibits apoptosis in Zucker diabetic rats.
    Farilla L; Hui H; Bertolotto C; Kang E; Bulotta A; Di Mario U; Perfetti R
    Endocrinology; 2002 Nov; 143(11):4397-408. PubMed ID: 12399437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic effect of dimethyl sulfoxide on glucagon-like peptide 1 (GLP-1)-stimulated insulin secretion and gene transcription in INS-1 cells: characterization and implications.
    Kemp DM; Habener JF
    Biochem Pharmacol; 2002 Aug; 64(4):689-97. PubMed ID: 12167488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.